12615 Results

People

  1. Ladanyi
    Ladanyi
  2. Reuter
    Reuter
  3. Antonescu
    Antonescu
  4. Berger
    Berger
  5. Travis
    Travis
  6. Shia
    Shia
  7. Busam
    Busam
  8. Al-Ahmadie
    Al-Ahmadie
  9. Arcila
    Arcila
  10. Weigelt
    Weigelt

Groups

  1. Department of Pathology and Laboratory Medicine (12615)
  2. GSK Faculty (4773)
  3. Department of Medicine (4722)
  4. Surgery (3639)
  5. Solid Tumor Oncology Division (3422)
  6. Human Oncology and Pathogenesis Program (3037)
  7. Tow Center for Developmental Oncology (TCDO) (2643)
  8. Sloan Kettering Institute Postdocs (2500)
  9. Survivorship Research (2113)
  10. Epidemiology and Biostatistics (2024)
  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (6438)
  2. Meeting Abstract (5172)
  3. Review (332)
  4. Book Section (310)
  5. Editorial (92)
  6. Research Letter (73)
  7. Guidelines (52)
  8. Correspondence (47)
  9. Conference Paper (38)
  10. Miscellaneous (37)
  11. Book Whole (24)
Groups
  1. Department of Pathology and Laboratory Medicine (12615)
  2. GSK Faculty (4773)
  3. Department of Medicine (4722)
  4. Surgery (3639)
  5. Solid Tumor Oncology Division (3422)
  6. Human Oncology and Pathogenesis Program (3037)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Victor Reuter (1228)
  3. Cristina Antonescu (895)
  4. Michael Berger (765)
  5. William Travis (743)
  6. Jinru Shia (719)

More People

Years
  1. 2025 (307)
  2. 2024 (719)
  3. 2023 (766)
  4. 2022 (841)
  5. 2021 (677)
  6. 2020 (787)

More Years

Publications
  1. Laboratory Investigation (1448)
  2. Modern Pathology (1440)
  3. Journal of Clinical Oncology (863)
  4. American Journal of Surgical Pathology (429)
  5. Cancer Research (426)
  6. Blood (349)

More Publications

Publishers
  1. Nature Publishing Group (1939)
  2. Nature Research (1457)
  3. Elsevier Inc. (1139)
  4. American Society of Clinical Oncology (955)
  5. American Association for Cancer Research (923)
  6. Lippincott Williams & Wilkins (896)

More Publishers

Results (12615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The clinical behavior of endometrioid and serous endometrial carcinomas is governed by distinct biological processes
    Meeting Abstract

    Weigelt, B.; Lemetre, C.; Ng, C. K. Y.; Piscuoglio, S.; Reis, J. S.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Dystrophin is a tumor suppressor in human cancers with myogenic programs
    Meeting Abstract

    Wang, Y. X.; Marino-Enriquez, A.; Bennett, R.; Zhu, M. J.; Eilers, G.; Antonescu, C.; Fletche, C.; Raut, C.; van de Rijn, M.; Kunkel, L.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Application of a multiplexed fluorescence microscopy method (MultiOmyx (TM)) to dissect proteomic biomarkers of (18)F-fluorodeoxy-glucose ((18)FDG) uptake in breast cancer
    Meeting Abstract

    Sood, A.; Miller, A. M.; Ginty, F.; McDonough, E.; Sui, Y. X.; Bordwell, A.; Li, Q.; Kaanumalle, S.; Pang, Z. Y.; Torres, F.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Glioma-associated IDH mutation induces miR-34a repression and stem cell-like physiology through enhanced PDGF signaling
    Meeting Abstract

    Silber, J.; Harinath, G.; Parthasarathy, P. T.; Fabius, A. W. M.; Turcan, S.; Chan, T. A.; Huse, J. T.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Targeted capture next generation sequencing of fresh frozen lobular carcinoma in situ and invasive lobular cancer identifies a common repertoire of mutations
    Meeting Abstract

    Sakr, R. A.; Scarpa, J. V. ; Schizas, M.; Giri, D.; De Brot, M.; Towers, R.; Ng, C. K. Y.; Lim, R.; Andrade, V. P.; Weigelt, B.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Acquired resistance to rapamycin and mTOR kinase inhibitors is mediated by non-overlapping mutations in distinct sites in the mTOR protein
    Meeting Abstract

    Rodrik - Outmezguine, V. S.; Yao, Z.; Mukherjee, R.; Cai, L.; Barratt, D.; Ward, R.; Klinowska, T.; Destanchina, E.; Berger, M.; Baselga, J.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Dual lineage inhibition of ETV1 and KIT disrupts the ETV1-KIT feed forward circuit and potentiates imatinib antitumor effect in GIST oncogenesis
    Meeting Abstract

    Ran, L.; Sirota, I.; Cao, Z.; Murphy, D.; Shukla, S.; Rossi, F.; Wongvipat, J.; Tap, W. D.; Besmer, P.; Antonescu, C. R.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Benchmarking algorithms for mutation impact prediction using functionally validated missense mutations
    Meeting Abstract

    Martelotto, L. G.; Zhang, Y.; Ng, C. K. Y.; Piscuoglio, S.; Reis, J. S.; Weigelt, B.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • SMARCA4 mutations in small cell carcinoma of the ovary
    Meeting Abstract

    Jelinic, P.; Mueller, J.; Olvera, N.; Dao, F.; Scott, S. N.; Shah, R.; Gao, J. J.; Schultz, N.; Gonen, M.; Soslow, R. A.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • A phase II study of afatinib (A) in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab (T) refractory esophagogastric (EG) cancer
    Meeting Abstract

    Janjigian, Y. Y.; Imtiaz, T.; Ilson, D. H.; Solit, D. B.; Berger, M. F.; Vakiani, E.
    Cancer Research (2014)

    Fulltext@MSK | Save